Aethlon Medical, Inc. (AEMD:NASDAQ) closed at $5.53 on November 11, 2026, down 0.36% on the day. The stock trades 78.4% below its 52-week high of $25.65 and 292.2% above its 52-week low of $1.41. Over the past year, it gained 31.7%. Aethlon Medical, Inc. is part of the Capital Goods sector (Biotechnology: Laboratory Analytical Instruments).
In 252 trading sessions since November 11, 2025, AEMD closed higher on 99 days (39%). Its best day was February 23, 2026 (+392.54%) and its worst was June 25, 2026 (-27.05%). The stock moved 10% or more in a single session 24 times. It opened at least 5% above the previous day's high 5 times.
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in cancer, infectious diseases, and other life-threatening conditions in the United States. The company develops Aethlon Hemopurifier, a medical device, which targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Its Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. The company is also involved in developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. Aethlon Medical, Inc. was founded in 1991 and is based in San Diego, California.
Find more stocks like AEMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.